Publications

5891 Results

Rituximab-CHOP versus CHOP with or without maintenance rituximab in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL): an update

Authors
TM Habermann;E Weller;VA Morrison;PA Cassileth;J Cohn;S Dakhil;RD Gascoyne;B Woda;R Fisher;BA Peterson;SJ Horning
Journal / Conference
Blood 104(11): #127
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
E4494

Impact of increased body weight on acute toxicity and outcome of autologous stem cell transplantation for non-Hodgkin's lymphoma: a Southwest Oncology Group analysis

Authors
P Stiff;J Unger;S Forman;M LeBlanc;T Miller;O Press;J Thompson;R Fisher
Journal / Conference
Blood 104(11): #352
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9438

Effect of adding rituximab to three cycles of CHOP plus invoved-field radiotherapy for limited-stage aggressive diffuse B-cell lymphoma (SWOG-0014).

Authors
TP Miller;JM Unger;C Spier;B Stea;E Cantu;M LeBlanc;RI Fisher
Journal / Conference
Blood 104(11): #158
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
S0014

New treatment options have changed the natural history of follicular lymphoma

Authors
RI Fisher;M LeBlanc;OW Press;DG Maloney;TP Miller
Journal / Conference
Blood 104(11): #583
Year
2004
Research Committee(s)
Lymphoma

Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall sirvival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update o fthe results of Intergroup study INT-0116 (SWOG 9008)

Authors
JS Macdonald;S Smalley;J Benedetti;N Estes;DG Haller;JA Ajani;LL Gunderson;M Jessup;JA Martenson
Journal / Conference
American Society of Clinical Oncology GastrointestinaI Cancers Symposium #6
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies

Authors
JM Unger;M LeBlanc;IM Thompson;CA Coltman Jr
Journal / Conference
Urologic Oncology: Seminars and Original Investigations 22:362-368
Year
2004
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

Authors
RC Flanigan;G Mickisch;R Sylvester;C Tangen;H Van Poppel;ED Crawford
Journal / Conference
Journal of Urology 171:1071-1076
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8949

Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of Intergroup protocol 0130

Authors
JA Martenson Jr;CG Willett;DJ Sargent;JA Mailliard;JH Donohue;LL Gunderson;CR Thomas Jr;B Fisher;AB Benson;R Myerson;RM Goldberg
Journal / Conference
Journal of Clinical Oncology 22(16):1-7
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9303 (INT-0130) (NCCTG-91-46-52)

Downregulated antioxidant defense enzyme expression is correlated with poor survival in DLBCL

Authors
DB Johnson;ME Tome;LM Rimsza;RA Roberts;LW Browne;TM Grogan;TP Miller;MM Briehl
Journal / Conference
Federation of American Societies for Experimental Biology 18(5):A953 (#626.6)
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Follicular lymphoma international prognostic index

Authors
P Solal-Celigny;P Roy;P Colombat;J White;JO Armitage;R Arranz-Saez;WY Au;M Bellei;P Brice;D Caballero;D Coiffier;E Conde-Garcia;C Doyen;M Federico;RI Fisher;JF Garcia-Conde;C Gugliemi;A Hagenbeek;C Haioun;M LeBlanc;AT Lister;A Lopez-Guillermo;P McLaughlin;N Milpied;P Morel;N Mounier;SJ Proctor;A Rohatiner;P Smith;P Soubeyran;H Tilly;U Vitolo;PL Zinzani;E Zucca;E Montserrat
Journal / Conference
Blood 104(5):1258-1265
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809